Uneek Mehra
Chief Accounting Officer
4D Molecular Therapeutics, Inc. (FDMT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-09-11–present
-
4D Molecular Therapeutics, Inc. (FDMT)
Proxy statement
Current -
2023-09-11–2025-07-15
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | 4D Molecular Therapeutics, Inc. (FDMT) | Chief Financial and Business Officer | $545,752 | $823,899 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.